SCHEMBL7674967

SCHEMBL7674967

OCC1=NN=C(c2cccnc2)[N]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 5/20 0.50
MKNK2 Q9HBH9 5/20 0.50
CYP2A6 P11509 10/20 0.47
CYP3A4 P08684 5/20 0.47
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 2/20 0.47
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP2C9 P11712 4/20 0.40
CYP2C19 P33261 3/20 0.40
CYP2E1 P05181 2/20 0.40
CYP2B6 P20813 2/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7676187 0.83 CYP2A6 (0.47) MKNK1MKNK2CYP2A6CYP3A4ALDH1A1
SCHEMBL7673942 0.80 CYP2A6 (0.44) MKNK1MKNK2CYP2A6CYP3A4ALDH1A1
SCHEMBL7680080 0.80 NOTUM (0.39) ALDH1A1LMNAHPGDHTTHSD17B10
SCHEMBL7683441 0.79 CYP11B1 (0.49) MKNK1MKNK2CYP2A6CYP3A4ALDH1A1
SCHEMBL7674216 0.79 CYP2A6 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL7679937 0.78 NPC1 (0.48) CYP2A6CYP3A4ALDH1A1CYP1A2MAPT
SCHEMBL7680165 0.77 TBXAS1 (0.51)
SCHEMBL7678740 0.76 CYP2A6 (0.40) MKNK1MKNK2CYP2A6CYP3A4ALDH1A1
SCHEMBL7676360 0.76 CYP2A6 (0.40) MKNK1MKNK2CYP2A6CYP3A4ALDH1A1
SCHEMBL7680376 0.75 KDM4E (0.47) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP claimed
JP-3110467-B2 2000-11-20 JP claimed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP claimed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO claimed
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed